Bio-Techne said on Tuesday that it has inked a development and license agreement with Thermo Fisher Scientific to complete development of and commercialize Bio-Techne's ExoTru kidney transplant rejection test, a multigene urine-based assay.

On February 23, Lepu Biopharma Co., Ltd. was listed on Hong Kong Exchanges and Clearing Limited (HKEX), stock code: 2157.HK. The issue price is HKD 7.13 per share, and public offering raised about HKD 900 million.

Recently, Shenzhen Third People's Hospital/The Second Affiliated Hospital of Southern University of Science and Technology and Roche Diagnostics formally reached a strategic cooperation to jointly establish the "Roche Strategic Cooperation Hospital".

Hypoxia-triggered platinum supernanoparticles dissociated into ultrasmall platinum nanoclusters, which could be cleared by the kidney through urine, in response to the tumor microenvironment.

Illumina and Beckman Coulter Life Sciences said on Tuesday that they have partnered on application development for the Biomek NGenius next-generation library preparation system.

On the evening of February 18, Shenzhen YHLO Biotech Co., Ltd. announced that it received a purchase order from the Institute of Medical Biology Co., Ltd.. According to the purchase order, MBL will purchase antigen test kits from the YHLO, the total amount is approximately CNY 316 million.

British testing firm DnaNudge announced on Wednesday that it has partnered with Pantonic Health to launch its CovidNudge test in Australia.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.

While the word “mutation” may conjure up alarming notions, a mutation in brain immune cells serves a positive role in protecting people against Alzheimer’s disease.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.

On February 17, 2022, Roche Diagnostics China announced in Shanghai that it had reached a strategic partnership with Sanomede Medical Technology Co., Ltd. (hereinafter referred to as "Sanomede") to jointly launch a new RS600 Lab Automation System (LAS) for Chinese market.

Recently, Hong Kong has been hit by the epidemic continuously. On February 16, Kang Keren, senior vice president of Wondfo Biotech, said that in response to the epidemic in Hong Kong, Wondfo's "Anti-epidemic pioneer" is preparing to go to the front line and guarantee supply.

Thermo Fisher Scientific's solution for cell and gene therapies involves a combination of cold chain logistics, serialization compliance, and distribution

Researchers at the University of Toronto have identified hundreds of new proteins that could play a role in cystic fibrosis, and which may shed light on why some patients respond better than others to current therapies.

Pacific Biosciences reported after the close of the market on Tuesday that its fourth quarter 2021 revenues grew 33 percent year over year, while its full-year revenues jumped 65 percent.